Ameriprise’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.16M Buy
247,968
+154,193
+164% +$2.58M ﹤0.01% 2495
2025
Q1
$1.44M Sell
93,775
-53,874
-36% -$828K ﹤0.01% 3037
2024
Q4
$3.25M Buy
147,649
+5,494
+4% +$121K ﹤0.01% 2642
2024
Q3
$2.56M Sell
142,155
-5,562
-4% -$100K ﹤0.01% 2772
2024
Q2
$2.4M Buy
147,717
+51,184
+53% +$832K ﹤0.01% 2785
2024
Q1
$1.36M Sell
96,533
-1,020
-1% -$14.4K ﹤0.01% 3044
2023
Q4
$1.02M Buy
97,553
+334
+0.3% +$3.49K ﹤0.01% 3183
2023
Q3
$993K Buy
97,219
+5,145
+6% +$52.5K ﹤0.01% 3149
2023
Q2
$693K Sell
92,074
-25,681
-22% -$193K ﹤0.01% 3313
2023
Q1
$1.04M Sell
117,755
-2,157
-2% -$19.1K ﹤0.01% 3131
2022
Q4
$1.09M Buy
119,912
+46,525
+63% +$424K ﹤0.01% 3088
2022
Q3
$592K Sell
73,387
-63,902
-47% -$515K ﹤0.01% 3319
2022
Q2
$1.03M Sell
137,289
-40,130
-23% -$302K ﹤0.01% 3108
2022
Q1
$1.66M Buy
177,419
+88,758
+100% +$828K ﹤0.01% 2995
2021
Q4
$700K Sell
88,661
-7,125
-7% -$56.3K ﹤0.01% 3402
2021
Q3
$933K Sell
95,786
-33,817
-26% -$329K ﹤0.01% 3190
2021
Q2
$1.28M Sell
129,603
-101,621
-44% -$1.01M ﹤0.01% 3118
2021
Q1
$2.67M Sell
231,224
-20,107
-8% -$232K ﹤0.01% 2741
2020
Q4
$2.42M Sell
251,331
-285,116
-53% -$2.75M ﹤0.01% 2691
2020
Q3
$4.83M Buy
536,447
+198,491
+59% +$1.79M ﹤0.01% 2111
2020
Q2
$4.17M Sell
337,956
-254,557
-43% -$3.14M ﹤0.01% 2198
2020
Q1
$5.32M Sell
592,513
-13,003
-2% -$117K ﹤0.01% 1868
2019
Q4
$5.94M Buy
605,516
+302,970
+100% +$2.97M ﹤0.01% 2128
2019
Q3
$2.08M Buy
302,546
+81,765
+37% +$563K ﹤0.01% 2672
2019
Q2
$2.04M Buy
220,781
+61,539
+39% +$568K ﹤0.01% 2746
2019
Q1
$2.5M Sell
159,242
-40,492
-20% -$635K ﹤0.01% 2634
2018
Q4
$3.08M Sell
199,734
-33,340
-14% -$514K ﹤0.01% 2429
2018
Q3
$5.01M Buy
233,074
+47,293
+25% +$1.02M ﹤0.01% 2335
2018
Q2
$4.51M Sell
185,781
-8,252
-4% -$200K ﹤0.01% 2312
2018
Q1
$3.32M Buy
194,033
+97,322
+101% +$1.66M ﹤0.01% 2449
2017
Q4
$1.86M Sell
96,711
-1,356,425
-93% -$26.1M ﹤0.01% 2683
2017
Q3
$25.6M Sell
1,453,136
-1,131,229
-44% -$19.9M 0.01% 890
2017
Q2
$85.9M Buy
2,584,365
+1,295,794
+101% +$43M 0.04% 396
2017
Q1
$41.3M Buy
1,288,571
+756,441
+142% +$24.3M 0.02% 617
2016
Q4
$19.3M Buy
532,130
+32,692
+7% +$1.18M 0.01% 1022
2016
Q3
$23M Buy
499,438
+12,741
+3% +$586K 0.01% 851
2016
Q2
$24.4M Sell
486,697
-2,275,886
-82% -$114M 0.01% 800
2016
Q1
$148M Buy
2,762,583
+274,158
+11% +$14.7M 0.09% 228
2015
Q4
$163M Buy
2,488,425
+234,209
+10% +$15.4M 0.1% 208
2015
Q3
$127M Sell
2,254,216
-142,460
-6% -$8.04M 0.08% 246
2015
Q2
$142M Buy
2,396,676
+307,552
+15% +$18.2M 0.08% 244
2015
Q1
$130M Buy
2,089,124
+98,873
+5% +$6.16M 0.07% 265
2014
Q4
$114M Buy
1,990,251
+196,689
+11% +$11.3M 0.07% 296
2014
Q3
$96.4M Sell
1,793,562
-11,371
-0.6% -$611K 0.06% 325
2014
Q2
$94.6M Buy
1,804,933
+161,211
+10% +$8.45M 0.06% 320
2014
Q1
$86.9M Sell
1,643,722
-151,339
-8% -$8M 0.05% 345
2013
Q4
$71.9M Sell
1,795,061
-80,437
-4% -$3.22M 0.04% 399
2013
Q3
$70.9M Buy
1,875,498
+217,198
+13% +$8.21M 0.05% 421
2013
Q2
$65M Buy
+1,658,300
New +$65M 0.05% 440